Anchorage Capital Group, L.L.C.

In its 13F for Q1 2025 (holdings as of March 31, 2025, filed May 15, 2025), Anchorage Capital Group, L.L.C. reported 5 stock positions worth $239.9 million. Its top holding was Sentinelone Class A (S) at 37.4% of the portfolio, followed by Frontier Communications Pare (FYBR, 36.5%) and Roivant Sciences (ROIV, 20.3%). Its holdings were unchanged from Q4 2024.

Most Recent 13F
Q2 2026
Location
NEW YORK, NY
CIK
0001300714
Portfolio Value
$239.9M (Q1 2025)
SEC Filing
0000905148-25-001771 ↗ filed May 15, 2025

Holdings Value

0$100.0M$200.0M$300.0M$400.0M$500.0M Q1 2024: $377.5M Q1 2024 Q2 2024: $316.7M Q2 2024 Q3 2024: $374.8M Q3 2024 Q4 2024: $272.5M Q4 2024 Q1 2025: $239.9M $239.9M Q1 2025 Q2 2025: $258.7M Q2 2025 Q3 2025: $117.4M Q3 2025 Q4 2025: $88.6M Q4 2025 Q1 2026: $436.3M Q1 2026 Q2 2026: $450.5M Q2 2026

Holdings 5 stocks · $239.9M

S Sentinelone Inc. Class A 37.42% 4,937,053 $89.8M No change
FYBR Frontier Communications Pare 36.53% 2,443,742 $87.6M No change
ROIV Roivant Sciences Ltd. 20.33% 4,832,642 $48.8M No change
DNA Ginkgo Bioworks Holdings Inc. 4.15% 1,746,363 $10.0M No change
AMBP Ardagh Metal Packaging SA 1.57% 1,250,000 $3.8M No change
Other holdings (2): bonds, preferreds, convertibles and warrants · $10.2M (not counted above)
SecurityClassShares / PrincipalValueChange
THE REALREAL INC (REAL 4 02/15/31) DEBT 4.000% 2/1 · principal 12,077,000$10.2MNew
AMPWF Ardagh Metal Packaging -CW26 *W EXP 08/04/202 1,245,385$23KNo change

Total filed on the 13F, all lines: $250.1M.

Portfolio Sells Q4 2024 → Q1 2025

None this quarter.

Portfolio Buys Q4 2024 → Q1 2025

None this quarter.

Notes & Other Activity Q4 2024 → Q1 2025

THE REALREAL INC (REAL 1 03/01/28) NOTE 1.000% 3/0 · principal Sold out 15,097,000 $11.7Mbefore exit
THE REALREAL INC (REAL 4 02/15/31) DEBT 4.000% 2/1 · principal New 12,077,000 $10.2M

Bonds, preferreds, convertibles and warrants; not part of the stock holdings or percentages above.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 3$450.5MEQPT, S, DNA
Q1 2026 3$436.3MEQPT, S, DNA
Q4 2025 2$88.6MS, DNA
Q3 2025 3$117.4MS, DNA, AMBP
Q2 2025 5$258.7MS, FYBR, ROIV, DNA, AMBP
Q1 2025 5$239.9MS, FYBR, ROIV, DNA, AMBP
Q4 2024 5$272.5MS, FYBR, ROIV, DNA, AMBP
Q3 2024 5$374.8MFYBR, S, ROIV, DNA, AMBP
Q2 2024 5$316.7MFYBR, S, ROIV, DNA, AMBP
Q1 2024 6$377.5MFYBR, S, DNA, ROIV, AMBP